Kinase, in vitro: An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.
BCR-ABL1	Y1007-p
ERK1	S523-p
ERK2	S523-p
JAK2	Y221-p , Y317-p , Y570-p , Y637-p , Y868-p , Y966-p , Y972-p
JAK2	Y1007-p

Putative in vivo kinases: An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.
Abl	Y1007-p , Y1008-p
BCR-ABL1	Y1007-p , Y1008-p
JAK2	Y119-p , Y201-p , Y206-p , Y221-p , Y570-p , Y637-p , Y813-p , Y868-p , Y913-p , Y918-p , Y931-p , Y934-p , Y940-p , Y966-p , Y972-p , Y1007-p , Y1008-p

Phosphatases, in vitro:
PTPRJ	Y813-p , Y868-p

Putative upstream phosphatases:
PTPRJ	Y813-p , Y868-p

Regulatory protein:
AR	Y1007-p , Y1008-p
BCR-ABL1	Y1007-p , Y1008-p
EPOR	Y221-p , Y570-p
EPOR	Y913-p , Y1007-p , Y1008-p
FCER1A	Y570-p
FLT3	Y570-p
IRS1	Y221-p
IRS2	Y221-p
SH2-B-beta	Y1007-p , Y1008-p
TLR3	Y1007-p

Treatment:
AG490	Y221-p , Y1007-p , Y1008-p
angiotensin	Y201-p
angiotensin_2	Y972-p
anti-CD3/CD28	Y1007-p
apigenin	Y221-p
bacterial infection	Y1007-p
CoCL2	Y1007-p , Y1008-p
EGF	S523-p , Y1007-p , Y1008-p
Epo	Y134-p , Y201-p , Y206-p , Y221-p , Y317-p , Y372-p , Y423-p , Y435-p , S523-p , Y570-p , Y637-p , S668-p , Y813-p , Y868-p , S904-p , Y913-p , Y966-p , Y1007-p , Y1008-p
exercise training	Y221-p
GH	Y221-p , S523-p , Y570-p , Y813-p , Y868-p , Y966-p , Y972-p , Y1007-p , Y1008-p
GM-CSF	Y221-p
IFN-gamma	Y221-p , S523-p
IL-3	Y317-p , S523-p , Y637-p , Y1007-p , Y1008-p
IL-3_withdrawal	Y1007-p , Y1008-p
imatinib	Y1007-p , Y1008-p
JAK2_inhibitor	Y1007-p
JAK_inhibitor_I	Y1007-p , Y1008-p
leptin	Y1007-p , Y1008-p
mifepristone	Y1007-p , Y1008-p
MPA	Y1007-p , Y1008-p
MPTP	Y1007-p , Y1008-p
PD98059	Y221-p
phorbol_ester	S523-p
PP2	Y1007-p , Y1008-p
U0126	S523-p